Tristel (LSE:TSTL) 3-Year Revenue Growth Rate : 10.00% (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Tristel 3-Year Revenue Growth Rate?

Tristel's Revenue per Share for the six months ended in Dec. 2024 was £0.47.

During the past 12 months, Tristel's average Revenue per Share Growth Rate was 11.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 10.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Tristel was 32.10% per year. The lowest was 0.70% per year. And the median was 10.60% per year.

Competitive Comparison of Tristel's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, Tristel's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tristel's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tristel's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Tristel's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Tristel 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Tristel (LSE:TSTL) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Tristel 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Tristel's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Tristel Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tristel PLC (LSE:TSTL) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

R1V:Germany

Address

Fordham Road, Unit 1B, Lynx Business Park, Newmarket, Snailwell, Cambridgeshire, GBR, CB8 7NY

Website

https://www.tristel.com

Tristel PLC is a player in the healthcare platform. The company is a manufacturer of chlorine dioxide chemistry used for the decontamination of medical devices. Its operating segments include three sectors, Hospital medical device decontamination products which are used predominantly for infection control in hospitals; manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates the majority of its revenue from Hospital medical device decontamination.

Tristel Headlines

No Headlines